Jim Simons Renaissance Technologies
Jim Simons is the founder of Renaissance Technologies, one of the most successful quantitative hedge funds in the world. Before his career in finance, he served as a mathematics professor and made significant contributions to differential geometry. Simons applied his analytical expertise to develop sophisticated, algorithm-driven trading strategies, earning consistently high returns for investors.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$798M |
| 2 |
Netflix
NFLX
|
+$608M |
| 3 |
UnitedHealth
UNH
|
+$517M |
| 4 |
Apple
AAPL
|
+$461M |
| 5 |
GE Vernova
GEV
|
+$296M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Broadcom
AVGO
|
+$527M |
| 2 |
Alphabet (Google) Class A
GOOGL
|
+$372M |
| 3 |
Meta Platforms (Facebook)
META
|
+$362M |
| 4 |
Advanced Micro Devices
AMD
|
+$328M |
| 5 |
Palantir
PLTR
|
+$327M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 19.57% |
| 2 | Healthcare | 15.8% |
| 3 | Consumer Discretionary | 12.38% |
| 4 | Financials | 11.53% |
| 5 | Industrials | 8.92% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2676
WisdomTree Bitcoin Fund
BTCW
$136M
| $697K | ﹤0.01% |
+6,100
| New | +$637K |
|
2677
State Street SPDR S&P Metals & Mining ETF
XME
$4.54B
| $692K | ﹤0.01% |
+10,300
| New | +$611K |
|
2678
Ovid Therapeutics
OVID
$521M
| $691K | ﹤0.01% |
2,095,309
+1,071,509
| +105% | +$323K |
|
2679
State Street SPDR S&P 400 Mid Cap Value ETF
MDYV
$2.89B
| $691K | ﹤0.01% |
8,700
-9,600
| -52% | -$727K |
|
2680
Hycroft Mining Holding Corp
HYMC
$2.55B
| $690K | ﹤0.01% |
220,579
+119,900
| +119% | +$392K |
|
|
HEPS
2681
D-Market Electronic Services & Trading
HEPS
$997M
| $690K | ﹤0.01% |
255,700
-91,800
| -26% | -$249K |
|
2682
Vinci Compass Investments Ltd
VINP
$622M
| $690K | ﹤0.01% |
71,332
+300
| +0.4% | +$2.89K |
|
2683
Quanterix
QTRX
$123M
| $686K | ﹤0.01% |
103,200
-99,721
| -49% | -$556K |
|
2684
Cracker Barrel
CBRL
$1.28B
| $686K | ﹤0.01% |
+11,232
| New | +$566K |
|
2685
iShares MSCI Emerging Markets Min Vol Factor ETF
EEMV
$3.61B
| $685K | ﹤0.01% |
+10,900
| New | +$656K |
|
2686
Meridian
MRBK
$240M
| $682K | ﹤0.01% |
52,900
+14,900
| +39% | +$197K |
|
|
ALMS
2687
Alumis Inc
ALMS
$3.19B
| $680K | ﹤0.01% |
+226,815
| New | +$1.07M |
|
2688
FNB Corp
FNB
$6.92B
| $675K | ﹤0.01% |
46,327
+29,300
| +172% | +$396K |
|
2689
Franklin Financial Services
FRAF
$287M
| $675K | ﹤0.01% |
19,500
+8,800
| +82% | +$325K |
|
|
PRO
2690
DELISTED
PROS Holdings
PRO
| $672K | ﹤0.01% |
+42,900
| New | +$730K |
|
2691
Caribou Biosciences
CRBU
$157M
| $670K | ﹤0.01% |
+532,121
| New | +$523K |
|
2692
Inovio Pharmaceuticals
INO
$110M
| $668K | ﹤0.01% |
328,129
+282,301
| +616% | +$541K |
|
2693
Morgan Stanley Direct Lending Fund
MSDL
$1.3B
| $667K | ﹤0.01% |
35,620
+20,856
| +141% | +$403K |
|
2694
TMC The Metals Company
TMC
$1.71B
| $666K | ﹤0.01% |
100,900
-408,100
| -80% | -$1.57M |
|
2695
Thryv Holdings
THRY
$95.5M
| $663K | ﹤0.01% |
54,500
-141,800
| -72% | -$1.83M |
|
2696
Oak Valley Bancorp
OVLY
$287M
| $661K | ﹤0.01% |
24,273
-4,000
| -14% | -$102K |
|
2697
Corvus Pharmaceuticals
CRVS
$1.24B
| $661K | ﹤0.01% |
165,188
-99,800
| -38% | -$363K |
|
2698
PLAYSTUDIOS Inc
MYPS
$64.3M
| $660K | ﹤0.01% |
503,600
+31,700
| +7% | +$43.5K |
|
2699
Unity Bancorp
UNTY
$616M
| $659K | ﹤0.01% |
14,000
+800
| +6% | +$34.5K |
|
2700
MGP Ingredients
MGPI
$377M
| $659K | ﹤0.01% |
+21,973
| New | +$653K |
|
Similar funds
Jim Simons's Q2 2025 Portfolio in Review
As of Q2 2025, Jim Simons held 4,018 positions worth $75.2B, up 14% from $66.1B the previous quarter. Its ten largest holdings account for 12% of the portfolio.
Jim Simons's Q2 2025 filing shows 612 new, 1,577 increased, 1,314 reduced and 496 closed positions. Its largest new stake was UnitedHealth: 1,352,129 shares worth $422M. The largest sale was Broadcom, an estimated $527M.
By sector, the portfolio is most concentrated in Technology at 20% of assets, up from 17% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- Jim Simons's largest Q2 2025 buy was UnitedHealth: 1,352,129 shares worth $422M.
- Jim Simons added most to NVIDIA in Q2 2025, an estimated $798M increase.
- Jim Simons's biggest Q2 2025 reduction was Broadcom, cutting an estimated $527M.
- Jim Simons fully exited Advanced Micro Devices in Q2 2025, selling an estimated $328M.
- Jim Simons's ten largest holdings make up 12% of its $75.2B portfolio in Q2 2025.
- Jim Simons opened 612 new positions and closed 496 in Q2 2025.
- Jim Simons's portfolio value rose 14% quarter-over-quarter to $75.2B.
Based on Renaissance Technologies's 13F filing for Q2 2025, filed 13 Aug 2025.